KIAA0101 mRNA overexpression in peripheral blood mononuclear cells acts as predictive marker for hepatic cancer

Tumor Biology

Volumn 35, Issue 3, 2014, Pages 2681-2686

  Su, Xiaomei ^a   Zhang, Tao ^a   Cheng, Peng ^a   Zhu, Yajie ^a   Li, Hua ^a   Li, Dong ^a   Liu, Zhen ^a   Gao, Hui ^a   Zhao, Zhenguo ^a   Zhao, Yu ^a   Liu, Huanyi ^a  

^a CHENGDU MILITARY GENERAL HOSPITAL   (China)

Author keywords

Biomarker; Hepatic cancer; KIAA0101; Overexpression; Peripheral blood mononuclear cells

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CD44V ANTIGEN; MESSENGER RNA;

ADULT; ARTICLE; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RISK; CANCER SURVIVAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GENE OVEREXPRESSION; GENETIC RISK; HUMAN; HUMAN CELL; KIAA0101 GENE; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PERIPHERAL BLOOD MONONUCLEAR CELL; PREDICTIVE VALUE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TUMOR GENE;

CARRIER PROTEINS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LEUKOCYTES, MONONUCLEAR; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84899078379     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-1353-3     Document Type: Article

References (31)

1. Kohles N, Nagel D, Jungst D, Durner J, Stieber P, Holdenrieder S. Prognostic relevance of oncological serum biomarkers in liver cancer patients undergoing transarterial undergoing transarterial chemoembolization therapy. Tumor Biol. 2012;33(1):33-40.
2. Jernal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69-90.
3. Siegel R, Ward E, Brawley O, Jernal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011;61(1):212-36.
4. EI-Serag HB. Hepatocellular carcinoma. N Eng J Med. 2011;365(12):1118-27.
5. Zhou J, Yu L, Gao X. Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. Int J Clin Oncol. 2011;29(36):4781-8.
6. Kung CI, Chen CY, Yang CC, Lin CY, Chen TH, Wang HS. The variant mRNA isofrom of human metastasis gene (CD44V) detected in the cell lines of human hepatocellular carcinoma. Biochem Mol Biol Int. 1994;32(2):233-8.
7. Dai L, Lei N, Liu M, Zhang JY. Autoantibodies to tumor-associated antigens as biomarker in human hepatocellular carcinoma (HCC). Exp Hematol Oncol. 2013;2(1):15.
8. Zhang X, Zhang Y, Li Y. Negative correlation of LIV-1 and E-cadherin expression in hepatocellular carcinoma cells. PLoS One. 2013;8(2):e56542.
9. Dong H, Tang J, Li LH, Ge J, Chen X, Ding J, et al. Serum carbohydrate antigen 19-9 as an indicator of liver metastasis in colorectal carcinoma cases. Asian Pac J Cancer Prev. 2013;14(2):909-13.
10. Mizutani K, Onda M, Asaka S, Akaishi J, Miyamoto S, Yoshida A, et al. Overexpressed in anaplastic thyroid carcinoma-1 (OEATC-1) as a novel gene responsible for anaplastic thyroid carcinoma. Cancer. 2005;103(9):1785-90.
11. Petroziello J, Yamane A, Westendorf L, Thompson M, McDonagh C, Cerveny C, et al. Suppression subtractive hybridization and expression profiling identifies a unique set of genes overexpressed in non-small-cell lung cancer. Oncogene. 2004;23(46):7734-45.
12. Yu P, Huang B, Shen M, Lau C, Chan E, Michel J, et al. p15 (PAF), a novel PCNA associated factor with increased expression in tumor tissues. Oncogene. 2001;20(4):484.
13. Simpson F, Lammerts BK, Buterfield N. The PCNA-associated factor KIAA0101/p15 binds the potential tumor suppressor product p33ING1b. Exp Cell Res. 2006;312(1):73-85.
14. Yuan RH, Jeng YM, Pan HW, Hu FC, Lai PL, Lee PH, et al. Overexpression of KIAA0101 predicts high stage, early tumor recurrence, and poor prognosis of hepatocellular carcinoma. Clin Cancer Res. 2007;13(18):5368-76.
15. Kais Z, Barsky SH, Mathsyaraia H, Zha A, Ransburgh DJ, He G, et al. KIAA0101 interacts with BRCA1 and regulates centrosome number. Mol Cancer Res. 2011;9(8):1091-9.
16. Hosokawa M, Takehara A, Matsuda K, Eguchi H, Ohigashi H, Ishikawa O, et al. Oncogenic role of KIAA0101 interacting with proliferating cell nuclear antigen in pancreatic cancer. Cancer Res. 2007;67(6):2568-76.
17. Kato T, Daigo Y, Aragaki M, Ishikawa K, Sato M, Kail M. Overexpression of KIAA0101 predicts poor prognosis in primary lung cancer patients. Lung Cancer. 2012;75(1):110-8.
18. Notterman DA, Alon U, Sierk AJ, Levine AJ. Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays. Cancer Res. 2001;61(7):3124-30.
19. Liu L, Chen X, Xie S, Zhang C, Qiu Z, Zhu F. Variant 1 of KIAA0101, overexpression in hepatocellular carcinoma, prevents doxorubicin-induced apoptosis by inhibitng p53 activation. Hepatology. 2012;56(5):1760-9.
20. Zhu K, Diao D, Dang C, Shi L, Wang J, Yan R, et al. Elevated KIAA0101 expression is a marker of recurrence in human gastric cancer. Cancer Sci. 2013;104(3):353-9.
21. Zhang M, Huang B. The multi-differentiation potential of peripheral blood mononuclear cells. Stem Cell Ther. 2012;3(6):48.
22. Bielecki M, Kowal K, Lapinska A, Chyczewski L, Kowal-Bielecka O. Increased release of soluble CD163 by the peripheral blood mononuclear cells is associated with worse prognosis in patients with systemic sclerosis. Adv Med Sci. 2013;58(1):126-33.
23. Matsumura N, Zembutsu H, Yamaguchi K, Sasaki K, Tsuruma T, Nishidate T, et al. Identification of novel molecular markers for detection of gastric cancer cells in the peripheral blood circulation using genome-wide microarray analysis. Exp Ther Med. 2012;2(4):705-13.
24. Terris B, Flejou JF, Ruszniewski P, Scoazec JY, Belghiti J, Potet F, et al. Increased expression of CD44v6 in endocrine pancreatic tumours but not in midgut carcinoid tumours. Clin Mol Pathol. 1996;49(4):203-8.
25. Zhang Z, Shibahara K, Stillman B. PCNA connects DNA replication to epigenetic inheritance in yeast. Nature. 2000;408(6809):221-5.
26. Wang X, Liang Y, Wang J, Wang M. Effect of NS-398, a cyclooxygenase-2 selective inhibitor, on the cytotoxicity of cytotoxic T lymphocytes to ovarian carcinoma cells. Tumor Biol. 2013;34(3):1517-22.
27. Zhu MC, Xu YJ, Zou X, Yan F. Down-regulation of HLA-A mRNA in peripheral blood mononuclear cell of colorectal cancer. Int J Color Dis. 2012;27(1):31-6.
28. Ma GF, Miao Q, Zeng XQ, Luo TC, Ma LL, Liu YM, et al. Transforming growth factor-beta1 and -beta2 in gastric precancer and cancer and roles in tumor-cell interactions with peripheral blood mononuclear cells in vitro. PLoS One. 2013;8(1):e54249.
29. Wang J, Wang X, Chen Y, Wan M, Xiang Z, Wu X, et al. Immunization with a HSP65-HER2 fusion peptide selectively eliminates HER2 B16 melanoma cells in a xenograft tumor mouse model. Tumor Biol. 2013;34(1):193-201.
30. Bendardaf R, Algars A, Elzagheid A. Comparison of CD44 expression in primary tumors and metastases of colorectal cancer. Oncol Rep. 2006;16(5):741-6.
31. Selcukbiricik F, Bilici A, Tural D, Erdamar S, Soyluk O, Buyukunal E, et al. Are high initial CEA and CA 19-9 levels associated with the presence of K-ras mutation in patients with metastatic colorectal cancer? Tumor Biol. 2013;34(4):2233-9.